Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC12277 structure
    GC12277MK 886
    CAS: 118414-82-7
    纯度: >99.50%

    A potent, selective inhibitor of FLAP

  • GC12288 structure
    GC12288GSK-J1 sodium salt
    CAS: 1797832-71-3

    A dual inhibitor of JMJD3 and UTX

  • GC12309 structure
    GC123097-Nitroindazole
    CAS: 2942-42-9

    A non-selective inhibitor of NOS isoforms

  • GC12325 structure
    GC12325BYK 191023 dihydrochloride
    CAS: 1216722-25-6

    A selective iNOS inhibitor

  • GC12330 structure
    GC12330SAR191801
    CAS: 1234708-04-3
    纯度: >99.50%

    SAR191801 是一种 hPGDS 抑制剂,在荧光偏振试验或 EIA 试验中的 IC50 为 12 nM。

  • GC12331 structure
    GC12331JC-1
    CAS: 3520-43-2
    纯度: >99.00% / >98.00% / >95.00%

    JC-1(CBIC2) is a cationic carbonyl cyanine fluorescent dye.

  • GC12342 structure
    GC12342NDT 9513727
    CAS: 439571-48-9
    纯度: >99.00%

    A competitive antagonist of the C5a receptor

  • GC12367 structure
    GC12367CM-272
    CAS: 1846570-31-7
    纯度: >98.00%

    An inhibitor of G9a, GLP, and DNA methyltransferases

  • GC12370 structure
    GC12370IKK-16 (hydrochloride)
    CAS: 1186195-62-9

    IKK-16 (hydrochloride)是一种新型的、具有口服活性的选择性IκB激酶(IKK)抑制剂,IKK-16作用于IKK-2、IKK复合物和IKK-1的IC 50 值分别为40nM、70nM和200nM

  • GC12399 structure
    GC12399BMS345541 hydrochloride
    CAS: 547757-23-3
    纯度: >99.50%

    A selective inhibitor of IKKα and IKKβ

  • GC12517 structure
    GC12517Sasapyrine
    CAS: 552-94-3
    纯度: >98.00%

    An NSAID and a prodrug form of salicylic acid

  • GC12520 structure
    GC12520Diphenyleneiodonium chloride
    CAS: 4673-26-1
    纯度: >99.50%

    二苯碘铵 (DPI) 氯化物 (DPIC) 作为 NADH/NADPH 氧化酶抑制剂,对 Mtb 和 S. aureus 具有有效的抗菌活性。

  • GC12532 structure
    GC12532CHPG
    CAS: 170846-74-9
    纯度: >98.00%

    A potent and selective mGluR5 agonist

  • GC12537 structure
    GC12537ATB-337
    CAS: 912758-00-0

    A hydrogen sulfide-releasing NSAID

  • GC12544 structure
    GC12544Hydroxychloroquine Sulfate
    CAS: 747-36-4
    纯度: >99.50%

    Hydroxychloroquine Sulfate是一种合成的4-氨基喹啉衍生物类抗疟药。

  • GC12555 structure
    GC12555GS-9620 (Vesatolimod)
    CAS: 1228585-88-3
    纯度: >99.50%

    GS-9620 (Vesatolimod)是一种具口服活性的有效的Toll样受体7(TLR7)激动剂,EC 50 值为291nM,具有抗病毒作用。

  • GC12567 structure
    GC12567TRIM
    CAS: 25371-96-4

    An inhibitor of nNOS and iNOS

  • GC12578 structure
    GC12578(R)-Lisofylline
    CAS: 100324-81-0
    纯度: >97.00% / >98.00%

    (R)-Lisofylline一种具有抗炎特性的小分子化合物,作为一种溶血磷脂酸酰基转移酶抑制剂(IC₅₀=0.6μM)。

  • GC12604 structure
    GC12604Fumonisin B1
    CAS: 116355-83-0
    纯度: >98.00% / >95.00%

    A mycotoxin

  • GC12609 structure
    GC12609PS 1145 dihydrochloride
    CAS: 1049743-58-9

    An IKKβ inhibitor

  • GC12628 structure
    GC12628ITE
    CAS: 448906-42-1
    纯度: >99.00%

    ITE是一种有效的免疫抑制性内源性芳香烃受体(AhR)激动剂,与AhR结合的K i 值为3nM。

  • GC12677 structure
    GC12677N-Benzylacetamidine (hydrobromide)
    CAS: 186545-76-6

    Potent, selective inhibitor of iNOS

  • GC12821 structure
    GC12821Oltipraz
    CAS: 64224-21-1
    纯度: >99.50%

    A Nrf2 and CAR activator

  • GC12867 structure
    GC12867L-NIO dihydrochloride
    CAS: 159190-44-0

    L-NIO dihydrochloride 是一种有效、非选择性和 NADPH 依赖性一氧化氮合酶 (NOS) 抑制剂,对神经元 (nNOS)、内皮细胞 (eNOS) 和诱导型 (iNOS) 的 Kis 分别为 1.7、3.9、3.9 μM 。